|
|
MesotheliomaInNews.com - is a resource for those seeking latest news about Mesothelioma Asbestos Cancer and Attorneys
What Mesothelioma is?
Pleural mesothelioma is an increasingly common type of lung cancer brought on by exposure to asbestos. When inhaled, asbestos fibers become embedded in the pleura, or outer lining of the lungs, leaving behind scarring and lesions. These lesions and scars eventually develop into full-blown pleural mesothelioma, a deadly form of lung cancer for which there is no cure. Asbestos fibers can also settle in the abdominal region, triggering the development of peritoneal mesothelioma. This type of lung cancer is equally dangerous
Latest News
Lung Cancer Trial Targets Asbestos-Related Disease
MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that's almost always caused by exposure to asbestos.
Read more
News Source - HealthDay via Yahoo! News
Publish date - 16:03:40 07/21/08
Mesothelioma Victims Center The 100% Help Center For Asbestos Related Cancer
According to Americas Watchdog, "if a mesothelioma victim, or the loved one of a mesothelioma victim wants free advice, or help on what to do after a diagnosis of Mesothelioma, we are the absolute best place in the world to call. Not only will we assist in finding the best law firm, but we will help you with everything else". Mesothelioma victims or loved ones of US mesothelioma can call the ...
Read more
News Source - PRWeb
Publish date - 10:15:05 07/21/08
Mesothelioma Victims Center The 100% Help Center For Asbestos Related Cancer
According to Americas Watchdog, "if a mesothelioma victim, or the loved one of a mesothelioma victim wants free advice, or help on what to do after a diagnosis of Mesothelioma, we are the absolute best place in the world to call.
Read more
News Source - PRWeb via Yahoo! News
Publish date - 07:54:11 07/21/08
Lung Cancer Trial Targets Asbestos-Related Disease
MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the...
Read more
News Source - ABC 7 El Paso
Publish date - 15:19:08 07/22/08
Lung Cancer Trial Targets Asbestos-Related Disease
Title: Lung Cancer Trial Targets Asbestos-Related Disease Category: Health News Created: 7/22/2008 2:00:00 AM Last Editorial Review: 7/22/2008
Read more
News Source - MedicineNet.com
Publish date - 19:27:46 07/22/08
LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims
LegalView updated readers to an alarming prediction by researchers who said the number of female mesothelioma victims may increase within the next few years. Researchers said that asbestos in hair dryers that were previously unregulated may be the cause. (PRWeb Jul 21, 2008) Read the full story at http://www.prweb.com/releases/2008/07/prweb1127814.htm
Read more
News Source - PRWeb
Publish date - 10:10:51 07/21/08
LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims
LegalView updated readers to an alarming prediction by researchers who said the number of female mesothelioma victims may increase within the next few years. Researchers said that asbestos in hair dryers that were previously unregulated may be the cause.
Read more
News Source - PRWeb via Yahoo! News
Publish date - 08:36:08 07/21/08
Rosetta-based cancer test wins first approval
The New York State Department of Health has approved a test for lung cancer based on the company's microRNA technology.
Read more
News Source - Globes Online
Publish date - 17:57:00 07/22/08
First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read more
News Source - Medical News Today
Publish date - 11:12:49 07/23/08
Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone ...
Alfacell Corporation today announced that a paper published in Molecular Cancer Therapeutics (2008; 7:1871-9) reports that a combination of ONCONASE and the thiazolidinedione antidiabetic drug rosiglitazone shows a promising effect for cancers with increased expression of PI3K-dependent Fra-1 expression or Survivin.
Read more
News Source - PR Newswire via Yahoo! Finance
Publish date - 12:33:05 07/21/08
Lung Cancer Trial Targets Asbestos-Related Disease
Copyright © 2008 ScoutNews LLC. All rights reserved.
Read more
News Source - HealthCentral.com
Publish date - 17:09:31 07/21/08
Rosetta Genomics Completes Acquisition Of Parkway Clinical Laboratories Inc.
Rosetta Genomics Ltd., a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has successfully completed the acquisition of Parkway Clinical Laboratories Inc., a privately-held company owning a CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of ...
Read more
News Source - BioresearchOnline
Publish date - 17:32:01 07/24/08
F1: The full verdict in Mosley's privacy case
The full verdict handed out by The Honourable Mr Justice Eady of the London High Court in the case of Max Mosley versus News of the World
Read more
News Source - autosport.com
Publish date - 23:19:42 07/24/08
HOME PAGE
Insurance players now see scope for more FDI Cos nearing 10th year of operations may look at listing option. Mumbai, July 23 The Government’s winning of the trust vote has raised the insurance industry’s hopes of seeing foreign direct investment in the sector being raised ...
Read more
News Source - The Hindu
Publish date - 18:38:13 07/24/08
|